Iqvia Holdings Financial Indicators Patterns

We strongly advise you to harness Iqvia Holdings fundamental analysis to find out if markets are presently mispricing the organization. In other words this interface allows you to validate available fundamentals of Iqvia Holdings as well as the relationship between them. We found thirty-six available reported financial drivers for Iqvia Holdings which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Iqvia Holdings fundamentals including its Net Income and the relationship between Book Value Per Share and Current Liabilities . As Iqvia Holdings appears to be a penny stock we also urge to confirm its Number of Shares Shorted numbers.
36%36%

Chance of Financial Distress

Iqvia Holdings has less than 36 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Iqvia Holdings Company Summary

Iqvia Holdings competes with Visa, Alphabet, Bristol Myer, Microsoft, and Amazon Com. Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific.

Iqvia Holdings Current Liabilities vs Shares Outstanding

Iqvia Holdings is rated below average in current liabilities category among related companies. It is rated below average in shares outstanding category among related companies creating about  0.13  of Shares Outstanding per Current Liabilities. The ratio of Current Liabilities to Shares Outstanding for Iqvia Holdings is roughly  7.67 

Iqvia Holdings Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also Your Equity Center. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Search macroaxis.com